ENDPOINTS

Moderna earnings: Losses narrow as biotech cuts costs

Moderna is working on restoring investors' faith that its Covid-19 vaccine was n...

Labs fear future funding cuts with Trump administration...

A series of actions by President Donald Trump's administration have provoked pro...

David Baker lab makes de novo enzymes with AI

The lab of Nobel laureate David Baker keeps pushing the limits of what's possibl...

Knownwell is betting on in-person weight management care

Knownwell, the Andreessen Horowitz and Flare Capital Partners-backed metabolic h...

Kennedy is confirmed by Senate as Trump's HHS secretary

The Senate on Thursday confirmed Robert F. Kennedy Jr. as Secretary of Health an...

Agios’ Pyrukynd succeeds in key trial of rare red blood...

Agios' blood disease treatment Pyrukynd passed a Phase 3 study in PK deficiency ...

Syngene CEO departs; Lilly and AdvanCell sign radiother...

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential ne...

Allay Therapeutics raises $45M for ongoing Series D; En...

Plus, news about Pliant Therapeutics, Blueprint Medicines, Galapagos and Atai: ...

Idorsia’s Tryvio licensing negotiations collapse amid c...

Idorsia’s plan to hand over the global rights to its blood pressure drug Tryvio ...

Neumora replaces CEO with ex-chief Berns after trial fa...

In a surprise move Thursday, Neumora remade its executive team and brought back ...

Sanofi faces $250M charge after J&J-partnered vaccine f...

Sanofi has been hit with a $250 million impairment charge after an E. coli vacci...

Hunger-suppressing biotech Aardvark raises $94M in IPO

Aardvark Therapeutics, a biotech looking to address hunger rather than appetite ...

Roche sends experimental CNS drugs to Newleos, a new bi...

Newleos Therapeutics emerged Thursday with $93.5 million and a bundle of oral sm...

Ex-DeepMind scientist launches AI biotech Latent Labs w...

Simon Kohl turned an internship at Google DeepMind into a key role in building A...

Novo's weight loss drug helps curb some drinking habits...

New research from the University of North Carolina-Chapel Hill found that Novo N...

NIH’s funding cut plan poses challenges for researchers...

An NIH cap on indirect cost payments for grant recipients is casting a shroud of...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.